Description

Movixicam ODT (meloxicam) tablets 15 mg. №10

Ingredients

Active ingredient: Meloxicam 15 mg per tablet.

Dosage

Recommended dosage: The usual dose is 15 mg taken once daily. It should be taken with a full glass of water.

Indications

Movixicam ODT tablets are indicated for the relief of pain and inflammation in conditions such as osteoarthritis and rheumatoid arthritis.

Contraindications

Do not use Movixicam ODT tablets if:

• You have a history of allergic reactions to meloxicam or other NSAIDs.
• You are in the third trimester of pregnancy.
• You have active peptic ulcers or gastrointestinal bleeding.

Directions

How to take: Place the tablet on the tongue, allow it to disintegrate, then swallow with or without water. Follow your doctor’s instructions carefully.

Scientific Evidence

Studies have shown that meloxicam, the active ingredient in Movixicam ODT tablets, is effective in reducing pain and inflammation associated with various arthritic conditions. One study published in the Journal of Rheumatology demonstrated that meloxicam provided significant pain relief and improved joint function in patients with osteoarthritis.

Additional Information

Movixicam ODT tablets should be stored at room temperature away from moisture and heat. Keep out of reach of children. If you experience any severe side effects or allergic reactions, seek medical help immediately.

Pharmacological Effects

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the enzymes responsible for inflammation in the body. It helps reduce pain, swelling, and stiffness by blocking the production of certain chemicals that cause these symptoms. This mechanism of action makes it an effective option for managing arthritis and other inflammatory conditions.

Clinical Trials and Comparative Effectiveness

In a comparative study published in the American Journal of Medicine, meloxicam was found to be as effective as other NSAIDs in relieving pain and improving function in patients with osteoarthritis. The study also highlighted the favorable gastrointestinal safety profile of meloxicam compared to some traditional NSAIDs, making it a preferred choice for long-term use in chronic conditions.